Abstract
An acute type rejection episode occurred in one of two patients treated with Interferon α (IFN α) for type C hepatitis (CHC).
Histopathological examination of the graft kidney revealed focal cellular infiltration and chronic transplant glomerulopathy which showed acute or chronic type rejection.
In spite of bolus administration of methyl-prednisolone, the elevation of serum creatinine level continued. After administration of anti-human lymphocyte globulin (AHLG), renal function improved, but urinary protein was still positive.
Another patient had no episode of rejection during or after IFN α therapy.
Similar content being viewed by others
References
Di Bisceglie, A. M., Martin, P., Kassianddies, C.: Recombinant interferon alpha therapy for chronic hepatitis C.N. Engl. J. Med., 21, 1506 (1989).
Pestka, S., Langer, J. A., Zoon, K. C.: Interferons and their actions.Ann. Rev. Biochem., 56, 727 (1987).
Heron, I., Hokland, M., Berg, K.: Enhancement expression of β2-microglobulin and HLA antigens of human lymphoid cells by interferon.Proc. Natl. Acad. Sci. USA, 75, 6215 (1978).
Averbach, S. D., Austin, H. A. III, Scherwin, S. A.: Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte α interferon therapy for myosis fungus.N. Engl. J. Med., 310, 32 (1989).
Selby, P., Kohn, J., Raymond, J.: Nephrotic syndrome during treatment with interferon.Br. Med. J., 290, 1190 (1985).
Fujikawa, H., Teraoka, S., Takahashi, K.: Interferon α therapy for non A and non B hepatitis and hepatitis B after renal transplantation.Proc. Jap. Transplant. Soc., 25, 259 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahara, S., Kakimoto, K., Kokado, Y. et al. Interferon α therapy for chronic active hepatitis type C after renal transplantation and allograft rejection. International Urology and Nephrology 27, 479–485 (1995). https://doi.org/10.1007/BF02550087
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550087